- $10.27m
- -$2.17m
- $9.51m
- 70
- 58
- 39
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 4.47 | ||
| PEG Ratio (f) | 0.06 | ||
| EPS Growth (f) | 250.19% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.86 | ||
| Price to Tang. Book | 0.86 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.07 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.44% | ||
| Return on Equity | -3.81% | ||
| Operating Margin | -9.81% | ||
Financial Summary
| Year End 31st Oct | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 21.56 | 20.12 | 19.4 | 16.98 | 9.51 | 11.8 | 12 | -13.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -1.42 | n/a | n/a | +30.34 | n/a | n/a | +22.22 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
Directors
- Last Annual
- October 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- January 14th, 2004
- Public Since
- November 8th, 2008
- No. of Shareholders
- 62
- No. of Employees
- 75
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 22,929,742
- Address
- Pharma-Bio Serv Building,#6 Road 696, DORADO, 00646
- Web
- https://www.pharmabioserv.com/
- Phone
- +1 7872782709
- Contact
- Scott Gordon
- Auditors
- Crowe PR PSC
Upcoming Events for PBSV
Q2 2025 Pharma-Bio Serv Inc Earnings Release
Q3 2025 Pharma-Bio Serv Inc Earnings Release
Similar to PBSV
1PM Industries
Pink Sheets on Nasdaq
3Dshopping.Com
Pink Sheets on Nasdaq
3 Sixty Risk Solutions
Pink Sheets on Nasdaq
Adecco AG
Pink Sheets on Nasdaq
Adm Endeavors
Pink Sheets on Nasdaq
FAQ
What is the Pharma-Bio Serv share price?
As of Today at 22:38 UTC, shares in Pharma-Bio Serv are trading at $0.45. This share price information is delayed by 15 minutes.
How has the Pharma-Bio Serv share price performed this year?
Shares in Pharma-Bio Serv last closed at $0.45 and the price had moved by -30.37% over the past 365 days. In terms of relative price strength the Pharma-Bio Serv share price has underperformed the S&P500 Index by -35.43% over the past year.
What are the analyst and broker recommendations for Pharma-Bio Serv?
There is no consensus recommendation for this security.
Find out moreWhat is the Pharma-Bio Serv dividend yield?
Pharma-Bio Serv does not currently pay a dividend.
Does Pharma-Bio Serv pay a dividend?
Pharma-Bio Serv does not currently pay a dividend.
When does Pharma-Bio Serv next pay dividends?
Pharma-Bio Serv does not currently pay a dividend.
How do I buy Pharma-Bio Serv shares?
To buy shares in Pharma-Bio Serv you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharma-Bio Serv?
As of the previous close price of $0.45, shares in Pharma-Bio Serv had a market capitalisation of $10.27m.
Where are Pharma-Bio Serv shares listed?
Here are the trading details for Pharma-Bio Serv:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PBSV
What kind of share is Pharma-Bio Serv?
Based on an overall assessment of its quality, value and momentum Pharma-Bio Serv is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharma-Bio Serv share price forecast for 2025?
The analyst consensus target price for shares in Pharma-Bio Serv is $1.50. That is 234.95% above the last closing price of $0.45.
Analysts covering Pharma-Bio Serv currently have a consensus Earnings Per Share (EPS) forecast of $0.09 for the next financial year.
Find out moreWhat is the trend in the Pharma-Bio Serv share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharma-Bio Serv. Over the past six months, its share price has underperformed the S&P500 Index by -11.52%.
As of the last closing price of $0.45, shares in Pharma-Bio Serv were trading -24.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharma-Bio Serv PE Ratio?
The Pharma-Bio Serv PE ratio based on its reported earnings over the past 12 months is 4.47. The shares last closed at $0.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharma-Bio Serv?
Pharma-Bio Serv's management team is headed by:
- Victor Sanchez - PRE
- Pedro Lasanta - CFO
- Howard Spindel - IND
- Irving Wiesen - IND